Thymus and immune reconstitution after allogeneic hematopoietic stem cell transplantation in humans: Never say never again

Tissue Antigens

Volumn 79, Issue 2, 2012, Pages 83-89

  Toubert, A ^a,b   Glauzy, S ^a,b   Douay, C ^a,b   Clave, E ^a,b  

^a INSERM   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Allogeneicity; Hematopietic stem cell transplantation; Immune reconstitution; T cell receptor excision circles; Thymus

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL AGING; CELL FUNCTION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; INFECTION; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; REVIEW; SURVIVAL; T LYMPHOCYTE; THYMUS; THYMUS FUNCTION; TISSUE PRESERVATION; TREATMENT OUTCOME;

ANIMALS; BIOLOGICAL ASSAY; CELL DIFFERENTIATION; CELL PROLIFERATION; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; MICE; OPPORTUNISTIC INFECTIONS; PROGNOSIS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SURVIVAL ANALYSIS; T-LYMPHOCYTES; THYMUS GLAND; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84855517500     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01820.x     Document Type: Review

References (43)

1. Mackall C, Fry T, Gress R, Peggs K, Storek J, Toubert A. Background to hematopoietic cell transplantation, including post transplant immune recovery. Bone Marrow Transplant 2009: 44: 457-62.
2. Seggewiss R, Einsele H. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. Blood 2010: 13: 3861-8.
3. Cavazzana-Calvo M, André-Schmutz I, Dal Cortivo L et al. Immune reconstitution after hematopoietic stem cell transplantation: obstacles and anticipated progress. Curr Opin Immunol 2009: 21: 544-8.
4. Roux E, Dumont-Girard F, Starobinski M et al. Recovery of immune reactivity after T cell-depleted bone marrow transplantation depends on thymic activity. Blood 2000: 96: 2299-303.
5. Storek J, Dawson MA, Storer B et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2011: 97: 3380-9.
6. Bains I, Antia R, Callard R, Yates AJ. Quantifying the development of the peripheral naive CD4+ T-Cell pool in humans. Blood 2009: 28: 5480-7.
7. Bouneaud C, Garcia Z, Kourilsky P, Pannetier C. Lineage relationships, homeostasis, and recall capacities of central-and effector-memory CD8 T cells in vivo. J Exp Med 2005: 201: 579-90.
8. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alpha beta T cell receptor diversity. Science 1999: 286: 958-61.
9. Gorski J, Yassai M, Zhu X, Kissela B, Keever C, Flomenberg N. Circulating T cell repertoire complexity in normal individuals and bone marrow recipients analyzed by CDR3 size spectratyping. Correlation with immune status. J Immunol 1994: 152: 5109-19.
10. Talvensaari K, Clave E, Douay C et al. Abroad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 2002: 99: 1458-64.
11. Wu CJ, Chillemi A, Alyea EP et al. Reconstitution of T-cell receptor repertoire diversity following T-cell depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood 2000: 95: 352-59.
12. Michalek J, Collins RH, Hill BJ, Brenchley JM, Douek DC. Identification and monitoring of graft-versus-host specific T-cell clone in stem cell transplantation. The Lancet 2003: 361: 1183-185.
13. Hakim FT, Memon SA, Cepeda R et al. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J CIin Invest 2005: 115: 930-9.
14. Douek DC, Mc Farland RD, Keiser PH et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998: 396: 690-5.
15. Dion ML, Sékaly RP, Cheynier R. Estimating thymic function through quantification of T-cell receptor excision circles. Methods Mol Biol 2007: 380: 197-213.
16. Dion ML, Poulin JF, Bordi R et al. HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation. Immunity 2004: 21: 757-68.
17. Azevedo RI, Soares MV, Barata JT et al. IL-7 sustains CD31 expression in human naive CD4+ T cells and preferentially expands the CD31+ subset in a PI3K-dependent manner. Blood 2009: 113: 2999-3007.
18. Lynch HE, Goldberg GL, Chidgey A et al. Thymic involution and immune reconstitution. Trends Immunol 2009: 30: 366-73.
19. Sempowski GD, Hale LP, Sundy JS et al. Leukemia inhibitory factor, oncostatin M, IL-6, and stem cell factor mRNA expression in human thymus increases with age and is associated with thymic atrophy. J Immunol 2000: 164: 2180-7.
20. Chen BJ, Deoliveira D, Spasojevic I et al. Growth hormone mitigates against lethal irradiation and enhances hematologic and immune recovery in mice and nonhuman primates. PLoS One 2010: 5: e11056.
21. Aves NL, Richard-Le Goff O, Nicholas D et al. Characterization of the thymic IL-7 niche in vivo. Proc Natl Acad Sci USA 2009: 106: 1512-17.
22. Hick RW, Gruver AL, Ventevogel MS et al. Leptin selectively augments thymopoiesis in leptin deficiency and lipopolysaccharide-induced thymic atrophy. J Immunol 2006: 177: 169-76.
23. Hauri-Hohl MM, Zuklys S, Keller MP et al. TGF-beta signaling in thymic epithelial cells regulates thymic involution and postirradiation reconstitution. Blood 2008: 112: 626-34.
24. Clave E, Rocha V, Talvensaari K et al. Prognostic value of pretransplantation host thymic function in HLA-identical sibling hematopoietic stem cell transplantation. Blood 2005: 105: 2608-13.
25. Petridou E, Klimentopoulou AE, Moustaki M, Kostrikis LG, Hatzakis A, Trichopoulos D. Recent thymic emigrants and prognosis in T- and B-cell Childhood hematopoietic malignancies. Int J Cancer 2002: 101: 74-7.
26. Svaldi M, Lanthaler AJ, Dugas M et al. T-cell receptor excision circles: a novel pronostic parameter for the outcome of transplantation in multiple myeloma patients. Br J Haematol 2003: 122: 795-801.
27. Chen X, Barfield R, Benaim E et al. Prediction of T-cell reconstitution by assessment of T-cell receptor excision circle before allogeneic hematopoietic stem cell transplantation in pediatric patients. Blood 2005: 105: 886-93.
28. Olkinuora H, Talvensaari K, Kaartinen T et al. T cell regeneration in pediatric allogeneic stem cell transplantation. Bone Marrow Transplant 2007: 39: 149-56.
29. Hazenberg MD, Otto SA, de Pauw ES et al. T-cell receptor excision circle and T-cell dynamics after allogeneic stem cell transplantation are related to clinical events. Blood 2002: 99: 3449-53.
30. Poulin JF, Sylvestre M, Champagne P et al. Evidence for adequate thymic function but impaired naive T-cell survival following allogeneic hematopoietic stem cell transplantation in the absence of chronic graft-versus-host disease. Blood 2003: 102: 4600-7.
31. Castermans E, Hannon M, Dutrieux J et al. Thymic recovery after allogeneic hematopoietic cell transplantation with non-myeloablative conditioning is limited to patients younger than 60 years of age. Haemetologica 2011: 96: 298-306.
32. Brown JA, Stevenson K, Kim HT et al. Clearance of CMV viremia and survival after double umbilical cord blood transplantation in adults depends on reconstitution of Thymopoiesis. Blood 2010: 115: 4111-9.
33. Na IK, Lu SX, Yim NL, Golberg GL et al. The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease. J Clin Invest 2010: 12: 343-56.
34. Clave E, Busson M, Douay C et al. Acute graft-versus-host disease transiently impairs thymic output in young patients after allogeneic hematopoietic stem cell transplantation. Blood 2009: 113: 6477-84.
35. Shono Y, Ueha S, Wang Y et al. Bone marrow graft-versus-host disease: early destruction of hematopoietic niche after MHC-mismatched hematopoietic stem cell transplantation. Blood 2010: 115: 5401-11.
36. Zakrzewski JL, Kochman AA, X Lu S et al. Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation. Nature Med 2006: 12: 1039-47.
37. Fewkes NM, Krauss AC, Guimond M, Meadors JL, Dobre S, Mackall CL. Pharmacologic modulation of niche accessibility via tyrosine kinase inhibition enhances marrow and thymic engraftment after hematopoietic stem cell transplantation. Blood 2010: 115: 4120-9.
38. Napolitano LA, Schmidt D, Gotway MB et al. Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest 2008: 118: 1085-98.
39. Sutherland JS, Spyroglou L, Muirhead JL et al. Enhanced immune system regeneration in humans following allogeneic or autologous hemopoietic stem cell transplantation by temporary sex steroid blockade. Clin Cancer Res 2008: 14: 1138-49.
40. Sportès C, Hakim FT, Memon SA et al. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008: 205: 1701-14.
41. Kelly RM, Goren EM, Taylor PA et al. Short-term inhibition of p53 combined with keratinocyte growth factor improves thymic epithelial cell recovery and enhances T-cell reconstitution after murine bone marrow transplantation. Blood 2010: 115: 1088-97.
42. Holland AM, Van Den Brink MRM. Rejuvenation of the aging T cell compartment. Curr Opin Immunol 2009: 21: 454-59.
43. Holländer GA, Krenger W, Blazar BR. Emerging strategies to boost thymic function. Curr Opin Pharmacol 2010: 10: 443-53.